ERBB2 and breast carcinoma: Since the AUC values obtained for NSMCE2 are usually values observed for top quality cancer biomarkers [27], our findings suggest that NSMCE2 expression could potentially be used to pinpoint a group of patients (especially those diagnosed with grade III TN or HER2 + breast cancer) that may not respond to chemotherapy.